|
|
|
|
Suppliers for
Astragaloside I
|
Properties | | CAS |
84680-75-1 | | Formula |
C45H72O16 |
|
|
4 Registered suppliers
Molecular Formula: C43H68O16 Molecular Weight: 840.99
More details are to be found here
Molecular Formula: C43H68O16 Molecular Weight: 840.99
More details are to be found here
Description : Astragaloside I is extracted from roots of Astragalus membranaceus (Fisch.) Bunge. It has anti-gastric effect. It has been shown to increase gastric pH without changing gastric volume or acid output. - Molecular Weight :869.04
- Boiling Point :911.8±65.0 °C | Condition: Press: 760 Torr
- Melting Point :246-250°C
- Purity :> 98%
Molecular Formula : C45H72O16 Canonical SMILES : CC(=O)OC1C(COC(C1OC(=O)C)OC2CCC34CC35CCC6(C(C(CC6(C5CC(C4C2)OC7C(C(C(C(O7)CO)O)O)O)C)O)C8(CCC(O8)C(C)(C)O)C)C)O
InChI :
InChI=1S/C43H68O16/c1-20(45)54-33-25(48)18-53-37(34(33)55-21(2)46)56-22-8-11-42-19-43(42)13-12-39(5)35(41(7)10-9-29(59-41)38(3,4)52)24(47)16-40(39,6)28(43)15-26(23(42)14-22)57-36-32(51)31(50)30(49)27(17-44)58-36/h22-37,44,47-52H,8-19H2,1-7H3/t22-,23?,24-,
InChIKey :
GBPDDYORNLOZID-ZHIISFHXSA-N
Solubility :
10 mM in DMSO
Appearance :
Powder
Application :
Astragaloside I has cardioprotective effects as well as causing improvement in cognitive function. It has anti-gastric effect and could increase gastric pH without changing gastric volume or acid output.
Storage : -20°C Freezer
Synonyms :
(3β,6α,16β,20R,24S)-3-[(2,3-Di-O-acetyl-β-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl β-D-glucopyranoside; Astrasieversianin IV; Cyclosieversioside B
More details are to be found here
Description : Astragaloside I is extracted from roots of Astragalus membranaceus (Fisch.) Bunge. It has anti-gastric effect. It has been shown to increase gastric pH without changing gastric volume or acid output. - Molecular Weight :869.04
- Boiling Point :911.8±65.0 °C | Condition: Press: 760 Torr
- Melting Point :246-250°C
- Purity :> 98%
Molecular Formula : C45H72O16 Canonical SMILES : CC(=O)OC1C(COC(C1OC(=O)C)OC2CCC34CC35CCC6(C(C(CC6(C5CC(C4C2)OC7C(C(C(C(O7)CO)O)O)O)C)O)C8(CCC(O8)C(C)(C)O)C)C)O
InChI :
InChI=1S/C43H68O16/c1-20(45)54-33-25(48)18-53-37(34(33)55-21(2)46)56-22-8-11-42-19-43(42)13-12-39(5)35(41(7)10-9-29(59-41)38(3,4)52)24(47)16-40(39,6)28(43)15-26(23(42)14-22)57-36-32(51)31(50)30(49)27(17-44)58-36/h22-37,44,47-52H,8-19H2,1-7H3/t22-,23?,24-,
InChIKey :
GBPDDYORNLOZID-ZHIISFHXSA-N
Solubility :
10 mM in DMSO
Appearance :
Powder
Application :
Astragaloside I has cardioprotective effects as well as causing improvement in cognitive function. It has anti-gastric effect and could increase gastric pH without changing gastric volume or acid output.
Storage : -20°C Freezer
Synonyms :
(3β,6α,16β,20R,24S)-3-[(2,3-Di-O-acetyl-β-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl β-D-glucopyranoside; Astrasieversianin IV; Cyclosieversioside B
More details are to be found here
|
|
|
Privileged suppliers
Last update 2024-04-30
|
details
details